← Back to screener

Guardant Health, Inc. GH

Rank #2513 · Nasdaq · $23.7B market cap
Audited by Deloitte & Touche LLP, no going-concern flag in the latest filing.
Score
9.7
P/E
-49.5
P/B
393.97
ROE
-796.7%
Op. Margin
-100.1%
Debt Ratio
2701%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Poor

P/E -49.5x, P/B 393.97x. Ranks in the top 84% of the universe.

Profitability ★☆☆☆☆
Poor

ROE -796.7%. Ranks in the top 94% of the universe.

Safety ★☆☆☆☆
Poor

Debt ratio 2701%. Ranks in the top 98% of the universe. Above 200% signals meaningful leverage risk.

Growth ★★★★☆
Excellent

Revenue growth of 25.5% year over year. Ranks in the top 14% of the universe.

Growth is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2018$0.0B$-0.0B$-0.0B$0.1B-173.741
2019$0.0B$-0.1B$-0.1B$0.1B-153.778
2020$0.1B$-0.1B$-0.1B$0.3B-102.537
2021$0.2B$-0.1B$-0.1B$0.5B-38.4190
2022$0.3B$-0.3B$-0.2B$0.8B-88.9195
2023$0.4B$-0.4B$-0.4B$1.3B-110.0119
2024$0.4B$-0.5B$-0.7B$0.6B-121.1252
2025$0.6B$-0.6B$-0.5B$0.1B-100.12701

← See the full screener